PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,000 | -93.0% | 32,000 | -50.8% | 0.00% | -100.0% |
| Q4 2019 | $115,000 | -65.2% | 65,000 | -11.7% | 0.01% | -77.8% |
| Q3 2019 | $330,000 | -86.6% | 73,597 | +77.0% | 0.03% | -78.0% |
| Q2 2018 | $2,459,000 | +1507.2% | 41,579 | -32.3% | 0.12% | +1437.5% |
| Q2 2017 | $153,000 | +537.5% | 61,400 | -32.2% | 0.01% | +700.0% |
| Q1 2017 | $24,000 | -29.4% | 90,500 | +575.4% | 0.00% | 0.0% |
| Q3 2016 | $34,000 | -96.0% | 13,400 | -78.0% | 0.00% | -96.8% |
| Q2 2014 | $842,000 | – | 60,959 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |